Increased Risk of Preeclampsia with Assisted Reproductive Technologies.
Assisted reproductive technology
Frozen embryo transfer
Hypertensive disorders of pregnancy
Preeclampsia
Pregnancy complications
Journal
Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
accepted:
19
05
2023
medline:
11
9
2023
pubmed:
12
6
2023
entrez:
11
6
2023
Statut:
ppublish
Résumé
We summarized recent available data to assess the association between assisted reproductive technology (ART) and risk for preeclampsia. The majority of clinical studies supporting the association of preeclampsia and ART are retrospective. Published data from both clinical and pre-clinical studies suggest specific ART procedures may contribute to the increased risk, including in vitro embryo handling and development, hormone stimulation, transfer cycle types, and use of donor oocytes/embryos. Potential mechanisms include epigenetic aberrations leading to abnormal placentation, absence of factors secreted by the corpus luteum, and immunologic responses to allogenic gametes. There is an increased risk of preeclampsia following ART. Treatment plans that favor reduced preeclampsia risk should be considered for ART pregnancies. To make ART pregnancies safer, additional clinical and animal model studies are needed to elucidate the underpinnings of this risk association.
Identifiants
pubmed: 37303020
doi: 10.1007/s11906-023-01250-8
pii: 10.1007/s11906-023-01250-8
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
251-261Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.